Press release
Sarcoidosis Treatment Market 2032: FDA Approval, Clinical Trials, Prevalence, Therapies and Companies by DelveInsight | Pfizer, United Therapeutics, Xentria, Inc., aTyr Pharma, Inc., Kyorin Pharma, Novartis, Kinevant Sciences GmbH, Foresee Pharma
Sarcoidosis Treatment Market
To Know in detail about the Sarcoidosis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Sarcoidosis Market Forecast
https://www.delveinsight.com/sample-request/sarcoidosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Some of the key facts of the Sarcoidosis Market Report:
• The Sarcoidosis market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
• In September 2022, aTyr Pharma, Inc. revealed the initiation of dosing for the initial patient in the worldwide pivotal EFZO-FIT™ trial. This Phase III study aims to assess the effectiveness and safety of the company's primary therapeutic candidate, efzofitimod, in comparison to a placebo among individuals diagnosed with pulmonary sarcoidosis, a significant type of interstitial lung disease (ILD).
• In August 2022, The FDA has awarded Fast Track designation to efzofitimod (ATYR1923) for addressing pulmonary sarcoidosis. Additionally, efzofitimod has obtained FDA orphan drug designation specifically for the treatment of sarcoidosis.
• DelveInsight's analysis revealed that the total number of existing cases of Sarcoidosis in the 7MM was reported to be 251,866 in 2022 and is projected to increase steadily with a notable compound annual growth rate (CAGR) over the study period.
• The United States reported the highest number of diagnosed prevalent cases of Sarcoidosis, estimated to be approximately 157,233 in 2022, with expectations of a substantial increase indicated by a significant compound annual growth rate (CAGR).
• In 2022, sarcoidosis affected 42% of males and 58% of females across the 7MM. Gender-specific instances in the EU4 and the UK totaled 35,297 for males and 50,450 for females in 2022, with projections indicating a rise within the forecast period (2023-2032).
• Key Sarcoidosis Companies: Pfizer, United Therapeutics, Xentria, Inc., aTyr Pharma, Inc., Kyorin Pharmaceutical Co., Ltd, Novartis, Kinevant Sciences GmbH, Foresee Pharmaceuticals, AI Therapeutics, Molecure, aTyr Pharma, and others
• Key Sarcoidosis Therapies: Abrocitinib, Inhaled Treprostinil, XTMAB-16, Efzofitimod, CMK389, Namilumab, FP-020, LAM001, OATD-01, and others
• A variety of emerging treatments for Sarcoidosis, such as KRP-R120 (efzofitimod), CMK389, OATD-01, XTMAB-16, among others, are under development. There remains a significant gap in effective therapies to address this disease. However, ongoing research and trials hold promise for potentially transforming the market landscape.
• The Sarcoidosis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Sarcoidosis pipeline products will significantly revolutionize the Sarcoidosis market dynamics.
Sarcoidosis Overview
Sarcoidosis is a rare inflammatory disease that can affect multiple organs in the body, most commonly the lungs and lymph nodes. In sarcoidosis, abnormal masses or nodules called granulomas form in certain organs of the body. These granulomas can alter the normal structure and function of the affected organs.
Get a Free sample for the Sarcoidosis Market Forecast, Size & Share Analysis Report:
https://www.delveinsight.com/report-store/sarcoidosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Sarcoidosis Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Sarcoidosis Epidemiology Segmentation:
The Sarcoidosis market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Sarcoidosis
• Prevalent Cases of Sarcoidosis by severity
• Gender-specific Prevalence of Sarcoidosis
• Diagnosed Cases of Episodic and Chronic Sarcoidosis
Download the report to understand which factors are driving Sarcoidosis epidemiology trends @ Sarcoidosis Epidemiology Forecast
https://www.delveinsight.com/sample-request/sarcoidosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Sarcoidosis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Sarcoidosis market or expected to get launched during the study period. The analysis covers Sarcoidosis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Sarcoidosis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Sarcoidosis Therapies and Key Companies
• Abrocitinib: Pfizer
• Inhaled Treprostinil: United Therapeutics
• XTMAB-16: Xentria, Inc.
• Efzofitimod: aTyr Pharma, Inc./Kyorin Pharmaceutical Co., Ltd
• CMK389: Novartis
• Namilumab: Kinevant Sciences GmbH
• FP-020: Foresee Pharmaceuticals
• LAM001: AI Therapeutics
• OATD-01: Molecure
Discover more about therapies set to grab major Sarcoidosis market share @ Sarcoidosis Treatment Landscape
https://www.delveinsight.com/sample-request/sarcoidosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Sarcoidosis Market Drivers
• Strategic alliances between the Pharmaceutical companies and universities, extensive research undertaking and funding are some of the important factors that are fueling the Sarcoidosis Market.
Sarcoidosis Market Barriers
• However, side-effects associated with the treatment of Sarcoidosis, lack of awareness among people in developing countries and other factors are creating obstacles in the Sarcoidosis Market growth.
Scope of the Sarcoidosis Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Sarcoidosis Companies: Pfizer, United Therapeutics, Xentria, Inc., aTyr Pharma, Inc., Kyorin Pharmaceutical Co., Ltd, Novartis, Kinevant Sciences GmbH, Foresee Pharmaceuticals, AI Therapeutics, Molecure, aTyr Pharma, and others
• Key Sarcoidosis Therapies: Abrocitinib, Inhaled Treprostinil, XTMAB-16, Efzofitimod, CMK389, Namilumab, FP-020, LAM001, OATD-01, and others
• Sarcoidosis Therapeutic Assessment: Sarcoidosis current marketed and Sarcoidosis emerging therapies
• Sarcoidosis Market Dynamics: Sarcoidosis market drivers and Sarcoidosis market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Sarcoidosis Unmet Needs, KOL's views, Analyst's views, Sarcoidosis Market Access and Reimbursement
To know more about Sarcoidosis companies working in the treatment market, visit @ Sarcoidosis Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/sarcoidosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Contents
1. Sarcoidosis Market Report Introduction
2. Executive Summary for Sarcoidosis
3. SWOT analysis of Sarcoidosis
4. Sarcoidosis Patient Share (%) Overview at a Glance
5. Sarcoidosis Market Overview at a Glance
6. Sarcoidosis Disease Background and Overview
7. Sarcoidosis Epidemiology and Patient Population
8. Country-Specific Patient Population of Sarcoidosis
9. Sarcoidosis Current Treatment and Medical Practices
10. Sarcoidosis Unmet Needs
11. Sarcoidosis Emerging Therapies
12. Sarcoidosis Market Outlook
13. Country-Wise Sarcoidosis Market Analysis (2019-2032)
14. Sarcoidosis Market Access and Reimbursement of Therapies
15. Sarcoidosis Market Drivers
16. Sarcoidosis Market Barriers
17. Sarcoidosis Appendix
18. Sarcoidosis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Trending Reports:
• 3d Cardiac Mapping System Market: https://www.delveinsight.com/report-store/3d-cardiac-mapping-system-market
• Acute Radiation Syndrome Market: https://www.delveinsight.com/report-store/acute-radiation-syndrome-market
• Adult Growth Hormone Deficiency Market: https://www.delveinsight.com/report-store/adult-growth-hormone-deficiency-aghd-market
• Alagille Syndrome Market: https://www.delveinsight.com/report-store/alagille-syndrome-market
• Aortic Aneurysm Stent Grafts Market: https://www.delveinsight.com/report-store/aortic-aneurysm-stent-grafts-market
• Atypical Teratoid Rhabdoid Tumors Market: https://www.delveinsight.com/report-store/atypical-teratoid-rhabdoid-tumors-market
• Brain Aneurysm Stents Market: https://www.delveinsight.com/report-store/brain-aneurysm-stents-market
• Chronic Bronchitis Market: https://www.delveinsight.com/report-store/chronic-bronchitis-market
• Chronic Myelogenous Leukemia Market: https://www.delveinsight.com/report-store/chronic-myelocytic-leukemia-cml-market
• Chronic Progressive Multiple Sclerosis Market: https://www.delveinsight.com/report-store/chronic-progressive-multiple-sclerosis-market
• Cutaneous Lupus Erythematosus Market: https://www.delveinsight.com/report-store/cutaneous-lupus-erythematosus-cle-market
• Encephalitis Market: https://www.delveinsight.com/report-store/encephalitis-market
• Refractory Chronic Cough Market: https://www.delveinsight.com/report-store/chronic-refractory-cough-market
• Acoustic Neuroma Market: https://www.delveinsight.com/report-store/acoustic-neuroma-market
• Aesthetic Implants Market: https://www.delveinsight.com/report-store/aesthetic-implants-market
• Aicardi-goutières Syndrome Market: https://www.delveinsight.com/report-store/aicardi-goutieres-syndrome-market
• Anemia In Ckd Market: https://www.delveinsight.com/report-store/anemia-in-chronic-kidney-disease-market
• Anovulation Market: https://www.delveinsight.com/report-store/anovulation-market
• Arthroscopic Shavers Market: https://www.delveinsight.com/report-store/arthroscopic-shavers-market
• Artificial Iris Market: https://www.delveinsight.com/report-store/artificial-iris-market
• Athlete's Foot Market: https://www.delveinsight.com/report-store/athletes-foot-market
• Automated External Defibrillators Market: https://www.delveinsight.com/report-store/automated-external-defibrillator-aed-market
• Bacteremia Market: https://www.delveinsight.com/report-store/bacteremia-market
• Biliary Atresia Market: https://www.delveinsight.com/report-store/biliary-atresia-market
• Biochips Market: https://www.delveinsight.com/blog/biochips-market-landscape
• Blood Glucose Monitoring Systems Market: https://www.delveinsight.com/report-store/blood-glucose-monitoring-systems-market
• Brain Cancer Market: https://www.delveinsight.com/report-store/brain-cancer-market
• Bunion Market: https://www.delveinsight.com/report-store/bunion-market
• Carcinoid Tumor Market: https://www.delveinsight.com/report-store/neuroendocrine-tumors-market
• Cardiac Insufficiency Market: https://www.delveinsight.com/report-store/congestive-heart-failure-market
• Cardiac Resynchronization Therapy Device Market: https://www.delveinsight.com/report-store/cardiac-resynchronization-therapy-market
• Central Retinal Venous Occulsion Market: https://www.delveinsight.com/report-store/retinal-vein-occlusion-market
• Cervical Cancer Market Size: https://www.delveinsight.com/report-store/cervical-cancer-market
• Cholangiocarcinoma Market: https://www.delveinsight.com/report-store/cholangiocarcinoma-cca-market-insights-epidemiology-and-market-forecast
• Chronic Refractory Cough Market: https://www.delveinsight.com/report-store/chronic-refractory-cough-market
• Diffuse Large B-cell Lymphoma Market: https://www.delveinsight.com/report-store/diffuse-large-b-cell-lymphoma-market
• Egfr Non-small Cell Lung Cancer Market: https://www.delveinsight.com/report-store/non-small-cell-lung-cancer-nsclc-market
• Emesis Market: https://www.delveinsight.com/report-store/emesis-market
• Endometriosis Pain Market: https://www.delveinsight.com/report-store/endometriosis-pain-market
Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/consulting/conference-coverage-services
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Sarcoidosis Treatment Market 2032: FDA Approval, Clinical Trials, Prevalence, Therapies and Companies by DelveInsight | Pfizer, United Therapeutics, Xentria, Inc., aTyr Pharma, Inc., Kyorin Pharma, Novartis, Kinevant Sciences GmbH, Foresee Pharma here
News-ID: 3652501 • Views: …
More Releases from DelveInsight Business Research
Gene therapy Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Pipelin …
(Albany, USA) DelveInsight's, "Gene Therapy Competitive Landscape 2024" report provides comprehensive insights about 250+ Gene Therapy companies and 300+ Gene Therapy drugs in the Gene therapy Competitive landscape. It covers the Gene Therapy therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Gene Therapy Competitive Landscape Report
• DelveInsight's Gene Therapy report depicts a robust…
Bispecific Antibody Clinical Trials 2024: FDA Approvals, Medications, Pipeline, …
(Albany, USA) DelveInsight's, "Bispecific antibody Competitive landscape" report provides comprehensive insights about 250+ Bispecific Antibody companies and 300+ Bispecific Antibody drugs in Bispecific antibody Competitive landscape. It covers the Bispecific Antibody therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Bispecific Antibody Competitive Landscape Report
• DelveInsight's Bispecific Antibody report depicts a robust space with…
CAR-T Cell Therapy Clinical Trials 2024: FDA Approvals, Medication, Therapies, M …
(Albany, USA) DelveInsight's, "CAR T Cell Therapy Competitive Landscape 2024" report provides comprehensive insights about 250+ CAR-T Cell Therapy companies and 500+ drugs in CAR T - Cell Therapy Competitive landscape. It covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the CAR-T Cell Therapy Report
• DelveInsight's CAR-T Cell Therapy report depicts a…
Spinal Muscular Atrophy Clinical Trials 2024 (Updated): EMA, PDMA, FDA Approval, …
(Albany, USA) Spinal Muscular Atrophy pipeline constitutes 18+ key companies continuously working towards developing 20+ Spinal Muscular Atrophy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Spinal Muscular Atrophy Pipeline Insight, 2024″ report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Spinal Muscular Atrophy Market.
The Spinal Muscular Atrophy Pipeline report embraces in-depth commercial and…
More Releases for Sarcoidosis
Sarcoidosis Drugs Market Size, Future Growth, Segments Forecast 2022-2028
Precision Business Insights published a research report on " Sarcoidosis Drug Market: By Product Type (Tumor Necrosis Factor Alpha (TNF-α) Inhibitors, Corticosteroids, Immunosuppressant Drugs, Others), By Route of Administration (Oral, Parenteral, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography - Global/Region/Country Forecast to 2028"
Sarcoidosis is an inflammatory disorder characterised by the growth of small collections of inflammatory cells. It can affect any organ in the body,…
Sarcoidosis Drug Market Expected To High Growth Over The Forecast To 2028
Data Bridge Market Research added recently released new research report on Sarcoidosis Drug Market 2021 by Top Manufacturers, Regions, Type and Application, Forecast provides updates and information related to industry coverage, current market competitive status, and market outlook.A wide ranging Sarcoidosis Drug market research report studies key opportunities in the market and influencing factors which is valuable for the businesses. The market analysis puts a light on various segments that…
Sarcoidosis Drug Market Is Thriving Worldwide by 2021-2027
Sarcoidosis is an illness portrayed by the development of small assortments of provocative cells (granulomas) in any piece of your body — most ordinarily the lungs and lymph hubs. Yet, it can likewise influence the eyes, skin, heart and different organs.
Get a Free Sample Report with All Related Graphs & Charts @
https://www.infinitybusinessinsights.com/request_sample.php?id=594216
the Sarcoidosis Drug market will be the Asia Pacific and Africa, where development will be at and separately.…
Sarcoidosis Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results
Sarcoidosis is an inflammatory disorder that affects many organs in the body, such as lymph glands and lungs. Abnormal nodules are formed in the affected organs, impacting the structure and function of the organ during sarcoidosis.
Download the sample report @ https://www.pharmaproff.com/request-sample/1052
The symptoms associated with this disease are fatigue; cough; swollen and painful joints; red and teary eyes or blurred vision; tender reddish bumps or patches on the skin; enlarged…
Sarcoidosis Therapeutics Market to Develop Rapidly by 2027
Sarcoidosis also known as Besnier-Boeck-Schaumann disease is an inflammatory disease characterized by formation of garnulomas. The autoagressive systemic disease affects the organs throughout the body where the nodules contains collection of inflammatory cells. In majority of the cases sarcoidosis is cured within a year or two and only 30% of the sarcoidosis develop chronic disease.
Request For Sample @https://www.futuremarketinsights.com/reports/sample/rep-gb-3340
The market for sarcoidosis therapeutics is expected to boom due to the number…
Sarcoidosis Therapeutics Market to Expand with Significant CAGR During 2027
Sarcoidosis also known as Besnier-Boeck-Schaumann disease is an inflammatory disease characterized by formation of garnulomas. The autoagressive systemic disease affects the organs throughout the body where the nodules contains collection of inflammatory cells. In majority of the cases sarcoidosis is cured within a year or two and only 30% of the sarcoidosis develop chronic disease.
Request for TOC @
https://www.futuremarketinsights.com/toc/rep-gb-3340
The market for sarcoidosis therapeutics is expected to boom due to…
